A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors-Reference-Cited by-同舟云学术

A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors

Published:2014-11-08 Issue:2 Volume:62 Page:274-278
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Radhakrishnan Kavita¹,Lee Alice²,Harrison Lauren A.¹,Morris Erin¹,Shen Violet³,Gates Laura³,Wells Robert J.⁴,Wolff Johannes E.⁵,Garvin James H.²,Cairo Mitchell S.¹⁶⁷⁸⁹

Affiliation:

1. Department of Pediatrics; New York Medical College; Valhalla New York

2. Department of Pediatrics; Columbia University; New York New York

3. Department of Pediatrics; Children's Hospital of Orange County; Orange California

4. Department of Pediatrics; University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Pediatrics; Tufts Medical Center; Boston Massachusetts

6. Department of Medicine; New York Medical College; Valhalla New York

7. Department of Pathology; New York Medical College; Valhalla New York

8. Department of Microbiology and Immunology; New York Medical College; Valhalla New York

9. Department of Cell Biology and Anatomy; New York Medical College; Valhalla New York

Funder

Glaxo Smith Kline

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference38 articles.

1. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: A Children's Cancer Group report;Abu-Ghosh;Ann Oncol,2002

2. Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: A Children's Cancer Group report;Cairo;J Pediatr Hematol Oncol,2001

3. Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: A Pediatric Oncology Group Phase I/II study;Kung;J Pediatr Hematol Oncol,1995

4. Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors;Kushner;Med Pediatr Oncol,2000

5. Topotecan in pediatric patients with recurrent and progressive solid tumors: A Pediatric Oncology Group phase II study;Nitschke;J Pediatr Hematol Oncol,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage;BMC Cancer;2016-01-05